Seelaus Asset Management’s Cytosorbents Corp CTSO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.4K | Hold |
18,300
| – | – | 0.02% | 175 |
|
|
2025
Q1 | $18.3K | Sell |
18,300
-500
| -3% | -$500 | 0.02% | 170 |
|
|
2024
Q4 | $17.1K | Hold |
18,800
| – | – | 0.02% | 168 |
|
|
2024
Q3 | $28.2K | Hold |
18,800
| – | – | 0.03% | 171 |
|
|
2024
Q2 | $13.2K | Sell |
18,800
-150
| -0.8% | -$105 | 0.01% | 171 |
|
|
2024
Q1 | $18K | Hold |
18,950
| – | – | 0.02% | 170 |
|
|
2023
Q4 | $21K | Sell |
18,950
-1,500
| -7% | -$1.67K | 0.02% | 180 |
|
|
2023
Q3 | $38.4K | Hold |
20,450
| – | – | 0.04% | 158 |
|
|
2023
Q2 | $73K | Hold |
20,450
| – | – | 0.06% | 184 |
|
|
2023
Q1 | $65K | Hold |
20,450
| – | – | 0.05% | 189 |
|
|
2022
Q4 | $32K | Sell |
20,450
-3,450
| -14% | -$5.4K | 0.02% | 196 |
|
|
2022
Q3 | $33K | Hold |
23,900
| – | – | 0.03% | 196 |
|
|
2022
Q2 | $52K | Hold |
23,900
| – | – | 0.04% | 205 |
|
|
2022
Q1 | $76K | Hold |
23,900
| – | – | 0.05% | 247 |
|
|
2021
Q4 | $100K | Buy |
23,900
+500
| +2% | +$2.09K | 0.05% | 250 |
|
|
2021
Q3 | $190K | Buy |
23,400
+500
| +2% | +$4.06K | 0.11% | 226 |
|
|
2021
Q2 | $173K | Sell |
22,900
-1,000
| -4% | -$7.56K | 0.1% | 238 |
|
|
2021
Q1 | $207K | Buy |
23,900
+1,200
| +5% | +$10.4K | 0.13% | 192 |
|
|
2020
Q4 | $181K | Buy |
22,700
+2,700
| +14% | +$21.5K | 0.13% | 176 |
|
|
2020
Q3 | $160K | Buy |
+20,000
| New | +$160K | 0.13% | 147 |
|